Stimulating Progress for Pharmacotherapy in Obesity Hypoventilation Syndrome
CHEST · 2026-04 · 169 (4) · 875-877
DOI: 10.1016/j.chest.2026.01.003 ↗Kurz gefasst
Editorial in der Zeitschrift CHEST, 2026-04. Verfasst von Nathan C Nowalk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Sleep Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: Nathan.Nowalk@PennMedicine.upen…. Die Arbeit nennt 10 Literaturangaben. Gefördert von: NHLBI NIH HHS, American Thoracic Society, National Heart, Lung, and Blood Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Sleep Medicine, Department of Medicine, University of Pennsylvania, Philadelphia, PA. Electronic address: Nathan.Nowalk@PennMedicine.upenn.edu.
- Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Rush University Medical Center, Chicago, IL.
Förderung
- NHLBI NIH HHS
- American Thoracic Society
- National Heart, Lung, and Blood Institute
- National Institutes of Health
- National Heart Lung and Blood Institute Division of Intramural Research
Zitieren
APA
Nowalk, N. C., & Mokhlesi, B. (2026). Stimulating Progress for Pharmacotherapy in Obesity Hypoventilation Syndrome. CHEST, 169(4), 875-877. https://doi.org/10.1016/j.chest.2026.01.003
Vancouver
Nowalk NC, Mokhlesi B. Stimulating Progress for Pharmacotherapy in Obesity Hypoventilation Syndrome. CHEST. 2026;169(4):875-877. doi:10.1016/j.chest.2026.01.003
BibTeX
@article{Nowalk2026,
author = {Nowalk, Nathan C and Mokhlesi, Babak},
title = {Stimulating Progress for Pharmacotherapy in Obesity Hypoventilation Syndrome},
journal = {CHEST},
year = {2026},
volume = {169},
number = {4},
pages = {875--877},
doi = {10.1016/j.chest.2026.01.003}
}
EUVIMED